#

Key Benefits

THE FIRST AND ONLY PROVEN ALTERNATIVE TO AUTOGRAFT IN ANKLE AND HINDFOOT ARTHRODESIS

  • Proven – Level 1 evidence of safety and effectiveness as a replacement to autograft in the largest F&A clinical trial ever conducted
  • Labeled – Class III combination product specifically proven in, and labeled for, ankle and hindfoot arthrodesis via a rigorous PMA regulatory pathway
  • Unique – The only biologic product specifically engineered, proven, and approved for ankle and hindfoot fusions
  • Safe – Proven safe through multiple clinical trials and successful commercial use since 2009 in Canada and 2011 in Australia and New Zealand, while eliminating the proven risks, morbidities, and costs associated with autograft harvest